Clinically-relevant ABC transporter for anti-cancer drug resistance
H Xiao, Y Zheng, L Ma, L Tian, Q Sun - Frontiers in pharmacology, 2021 - frontiersin.org
Multiple drug resistance (MDR), referring to the resistance of cancer cells to a broad
spectrum of structurally and mechanistically unrelated drugs across membranes, severely …
spectrum of structurally and mechanistically unrelated drugs across membranes, severely …
Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
H Zhang, H Xu, CR Ashby Jr, YG Assaraf… - Medicinal research …, 2021 - Wiley Online Library
Multidrug resistance (MDR) remains one of the major impediments for efficacious cancer
chemotherapy. Increased efflux of multiple chemotherapeutic drugs by transmembrane ATP …
chemotherapy. Increased efflux of multiple chemotherapeutic drugs by transmembrane ATP …
Anti-cancer chalcones: Structural and molecular target perspectives
Abstract Chalcone or (E)-1, 3-diphenyl-2-propene-1-one scaffold remained a fascination
among researchers in the 21st century due to its simple chemistry, ease of synthesis and a …
among researchers in the 21st century due to its simple chemistry, ease of synthesis and a …
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
The presence of multidrug resistance (MDR) in malignant tumors is one of the primary
causes of treatment failure in cancer chemotherapy. The overexpression of the ATP binding …
causes of treatment failure in cancer chemotherapy. The overexpression of the ATP binding …
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
A Hybrid drug which comprises the incorporation of two drug pharmacophores in one single
molecule are basically designed to interact with multiple targets or to amplify its effect …
molecule are basically designed to interact with multiple targets or to amplify its effect …
[HTML][HTML] Diverse molecular targets for chalcones with varied bioactivities
B Zhou, C Xing - Medicinal chemistry, 2015 - ncbi.nlm.nih.gov
Natural or synthetic chalcones with different substituents have revealed a variety of
biological activities that may benefit human health. The underlying mechanisms of action …
biological activities that may benefit human health. The underlying mechanisms of action …
Trends in utilization of the pharmacological potential of chalcones
DI Batovska, IT Todorova - Current clinical pharmacology, 2010 - ingentaconnect.com
Chalcones (1, 3-diaryl-2-propen-1-ones) are open chain flavonoids that are widely
biosynthesized in plants. They are important for the pigmentation of flowers and, hence, act …
biosynthesized in plants. They are important for the pigmentation of flowers and, hence, act …
Therapeutic potential of chalcones as cardiovascular agents
DK Mahapatra, SK Bharti - Life sciences, 2016 - Elsevier
Cardiovascular diseases are the leading cause of death affecting 17.3 million people across
the globe and are estimated to affect 23.3 million people by year 2030. In recent years …
the globe and are estimated to affect 23.3 million people by year 2030. In recent years …
Synthesis and evaluation of indole-based chalcones as inducers of methuosis, a novel type of nonapoptotic cell death
MW Robinson, JH Overmeyer, AM Young… - Journal of medicinal …, 2012 - ACS Publications
Methuosis is a novel caspase-independent form of cell death in which massive
accumulation of vacuoles derived from macropinosomes ultimately causes cells to detach …
accumulation of vacuoles derived from macropinosomes ultimately causes cells to detach …
Targeting efflux pumps to overcome antifungal drug resistance
AR Holmes, TS Cardno, JJ Strouse… - Future Medicinal …, 2016 - Taylor & Francis
Resistance to antifungal drugs is an increasingly significant clinical problem. The most
common antifungal resistance encountered is efflux pump-mediated resistance of Candida …
common antifungal resistance encountered is efflux pump-mediated resistance of Candida …